For research use only — not for human consumption

Senna Research

GHK-Cu plasma decline with age: copper, collagen and gene data

First isolated from human plasma in 1973, GHK-Cu has a gene-expression profile that is directional, not random, and plasma levels that fall by about 60% with age.

GHK-Cu research vial from Senna Research

Tissue repair slows with age, and researchers have tracked one specific signaling molecule alongside that change since the 1970s. GHK-Cu, a copper-binding tripeptide first isolated from human plasma in 1973, is one of the most extensively studied peptides in tissue-repair research. The more closely its gene-expression data is examined, the more specific the picture becomes.

A directional gene-expression signature

An analysis using the Broad Institute Connectivity Map found that GHK-Cu modulates roughly 4,048 genes at a significance threshold of p below 0.05. The count is large, but the direction of the changes is the more useful result.

  • Most of the affected genes are upregulated, including genes tied to DNA repair, antioxidant defense, and tissue remodeling.
  • A smaller share is downregulated, largely genes linked to inflammation and to degradation of the extracellular matrix.

The pattern is directional rather than random. A peptide that nudged thousands of genes in arbitrary directions would be hard to interpret. A signature that leans toward repair and away from matrix breakdown gives researchers a coherent hypothesis to test.

Why the copper matters

Copper is not incidental to this peptide. Lysyl oxidase, the enzyme that cross-links collagen and elastin into a stable matrix, is copper-dependent and needs bioavailable copper to function. Delivering copper through a peptide carrier is one proposed mechanism by which GHK-Cu could support that enzyme's activity in research models.

Plasma levels across the lifespan

Circulating GHK follows the same trajectory as repair capacity. Plasma concentrations sit near their peak in the 20s, at roughly 200 ng/mL, and fall to roughly 80 ng/mL by the 60s. That is a decline of about 60% from baseline.

This is a correlation across age groups, not proof that the decline causes slower repair. It does explain why GHK-Cu is studied as an age-associated signal rather than only as a wound-repair compound.

Sources

  • Pickart, Vasquez-Soltero and Margolina, GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration, 2015 (PMID 26236730).
  • Pickart and Margolina, Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data, 2018 (PMID 29986520).
  • Broad Institute Connectivity Map, GHK-Cu gene-modulation analysis (about 4,048 genes, p below 0.05).

Original post on X

Compounds in this article

Mandatory research disclaimer

All materials on this site are sold as laboratory reagents for research use only. They are not drugs, foods, cosmetics, dietary supplements, or medical devices, and are not for human or veterinary use of any kind.

Senna Research makes no claims of safety or efficacy and provides no usage, dosing, or preparation guidance; we publish analytical data only.

These materials have not been evaluated or approved by the U.S. Food and Drug Administration for any use.